Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: C. K. Humphries who wrote (3685)	4/30/1998 8:41:00 AM
From: Dauntless	Read Replies (1) of 7041

C. K. - happens all the time CIBA, at the time they licensed the drug to Zonagen, obviously thought they had bigger fish to fry. Happens all the time - Big pharma companies have more compounds than they could ever develop - prioritize and keep the ones they deem best for them - by licensing some of the rest they can get a better return on their research. The people at SGP got the chance to study the results of Phase I, II and III clinical trials - CIBA did not. Not necessarily smarter, just better informed. Same with the other three potential partners that negotiated for the distribution rights. Maybe they're all incapable of evaluating clinical data?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next